Moneycontrol PRO
HomeNewsIndiaDMRC launches survey to track travel patterns of commuters, avoid peak-hour rush

DMRC launches survey to track travel patterns of commuters, avoid peak-hour rush

The survey, titled 'Break the Peak', aims to help the Delhi metro avoid overcrowding in the metro trains and is also looking for the possibility of commuters planning their travel accordingly to prevent the spread of COVID-19.

October 14, 2020 / 16:26 IST

In order to avoid peak-hour overcrowding, the Delhi Metro Rail Corporation (DMRC) is conducting an online survey to study the travel pattern of its commuters.

The survey, titled 'Break the Peak', aims to help the Delhi metro avoid overcrowding in the metro trains and is also looking for the possibility of commuters planning their travel accordingly to prevent the spread of COVID-19.

It includes questions like timings of travel from home and from office, the place, profession of an individual, the flexibility of planning the travel in non-peak hours, and whether the commuters have an option to work from home.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The DMRC on its official twitter handle said, "Help us get to know your travel patterns better by taking part in the ‘break the peak’ survey. Fill out the form below so that we may understand your individual travel behaviour better."

The link for the online survey will be available till 27 October on the Delhi Metro Rail Corporation's social media pages, LiveMint reported.

The Delhi Metro resumed full services on September 12 after the months-long lockdown due to the COVID-19 pandemic. While the occupancy has been limited, in some lines, 100 percent occupancy during peak hours i.e. in the mornings and evenings has been witnessed.

Moneycontrol News
first published: Oct 14, 2020 04:26 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347